Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-08 10:48 am Sale | 13G | Edify Acquisition Corp. EAC | Bracebridge Capital LLC | 0 0.000% | -500,000 (Position Closed) | View |
| 2023-11-16 8:55 pm Sale | 13D | Mallinckrodt plc MNKTQ | Bracebridge Capital LLC | 1,093,857 5.600% | -939,400 (-46.20%) | View |
| 2023-08-24 6:23 pm Unchanged | 13D | Mallinckrodt plc MNKTQ | Bracebridge Capital LLC | 2,033,257 15.300% | 0 (Unchanged) | View |
| 2023-06-16 5:04 pm Unchanged | 13D | Mallinckrodt plc MNKTQ | Bracebridge Capital LLC | 2,033,257 15.440% | 0 (Unchanged) | View |
| 2023-06-14 7:28 pm Purchase | 13G | Edify Acquisition Corp. EAC | Bracebridge Capital LLC | 500,000 29.600% | 500,000 (New Position) | View |
| 2023-02-22 10:45 am Sale | 13D | Quotient Ltd QTNTF | Bracebridge Capital LLC | 81,614 0.400% | -44,089 (-35.07%) | View |
| 2022-12-15 5:09 pm Purchase | 13D | Quotient Ltd QTNTF | Bracebridge Capital LLC | 125,703 3.400% | 125,703 (New Position) | View |
| 2022-07-06 4:00 pm Unchanged | 13G | Clarus Therapeutics Holdings Inc. CRXT | Bracebridge Capital LLC | 2,002,495 54.000% | 0 (Unchanged) | View |
| 2022-06-27 4:02 pm Purchase | 13G | Mallinckrodt plc MNKTQ | Bracebridge Capital LLC | 2,033,257 15.440% | 2,033,257 (New Position) | View |
| 2022-02-14 11:34 am Sale | 13G | Clarus Therapeutics Holdings Inc. CRXT | Bracebridge Capital LLC | 2,002,495 8.300% | -227,360 (-10.20%) | View |
| 2021-09-17 4:15 pm Purchase | 13G | Clarus Therapeutics Holdings Inc. CRXT | Bracebridge Capital LLC | 2,229,855 10.300% | 2,229,855 (New Position) | View |